Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|May 10, 2019
Mutational patterns and regulatory networks in epigenetic subgroups of meningiomaNagarajan Paramasivam, Daniel Hübschmann, Umut H Toprak, et al.
Neuro-Oncology|October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|May 10, 2019
Mutational patterns and regulatory networks in epigenetic subgroups of meningiomaNagarajan Paramasivam, Daniel Hübschmann, Umut H Toprak, et al.
Neuro-Oncology|October 21, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)Matthias Preusser, Antonio Silvani, Emilie Le Rhun, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|June 29, 2019
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1Philipp Sievers, Romain Appay, Daniel Schrimpf, et al.
Acta Neuropathologica|December 15, 2020
Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1Philipp Sievers, Martin Sill, Christina Blume, et al.
Neuro-Oncology|January 22, 2025
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutantEmilie Le Rhun, Andrea Bink, Joerg Felsberg, et al.
Acta Neuropathologica Communications|January 11, 2022
Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survivalAzadeh Ebrahimi, Andrey Korshunov, Guido Reifenberger, et al.
Neuro-Oncology|April 19, 2023
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C Hardin, Simone Schmid, Alexander Sommerkamp, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|April 20, 2021
Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1Abigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Pageof 13